0.24 USD
▲+0.02+7.66%
盘后 0.41 0.00%
2026-09-16
市值
$18.06M
市盈率
—
EPS
-155.88
股息率
—
52 周区间
0.20 – 85.40
成交量
3.65M
Beta
-0.06
目标价
—
52W 低 0.2052W 高 85.40
价格走势
公司简介
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS...